Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Examining Trends in Prostate Cancer Diagnosis, Treatment and Mortality

Principal Investigator
Name
D. Duane Baldwin
Degrees
MD
Institution
Loma Linda University Health
Position Title
Professor of Urologic Surgery
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-247
Initial CDAS Request Approval
Jan 12, 2017
Title
Examining Trends in Prostate Cancer Diagnosis, Treatment and Mortality
Summary
The purpose of this study is to attempt to identify factors in the patient reported questionnaires that may aid clinicians in identifying patients at high risk for prostate cancer diagnosis and its implication on treatment and mortality. The group of patients with early mortality from prostate cancer would also be examined to determine the impact of PSA screening and treatment intervention on mortality outcomes.
Aims

1. To determine factors in the patient reported questionnaires that may aid in prostate cancer diagnosis
2. Evaluate the impact of PSA testing in symptomatic patients in terms of cancer diagnosis and mortality outcomes.
3. Identify patients at highest risk for prostate cancer related mortality

Collaborators

Muhannad Alsyouf (Loma Linda University Health)
Herbert C. Ruckle (Loma Linda University Health)
Brian Hu (Loma Linda University Health)